MISCELLANEOUS :: LONZA EXTENDS PARTNERSHIP WITH PHARMACYCLICS TO SUPPORT MANUFACTURING OF RECENTLY APPROVED ONCOLOGY THERAPEUTIC, IMBRUVICA
* Asterisks denote mandatory information
Name of Announcer *LONZA GROUP LTD
Company Registration No.CH-020.3.021.634-0
Announcement submitted on behalf of LONZA GROUP LTD
Announcement is submitted with respect to *LONZA GROUP LTD
Announcement is submitted by *Esther Au
Designation *SGXNET Authorised User
Date & Time of Broadcast13-Jan-2014 14:31:15
Announcement No.00025
 
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Announcement Title *Lonza Extends Partnership with Pharmacyclics to Support Manufacturing of Recently Approved Oncology Therapeutic, IMBRUVICA
Description
Please see attached
Attachments
140113_Pharmacyclics_e_final.pdf
Total size =28K
(2048K size limit recommended)